Historial de carrera de Jim Wang
Antiguos cargos conocidos de Jim Wang.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ADVERUM BIOTECHNOLOGIES, INC. | Consejero General | 23/04/2021 | 01/08/2023 |
PFIZER, INC. | Corporate Officer/Principal | - | - |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Director/Miembro de la Junta | - | - |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - | - |
SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
PTC THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Formación de Jim Wang.
University of Illinois | Doctorate Degree |
The Pennsylvania State University | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 8 |
Japón | 2 |
Operativa
Corporate Officer/Principal | 4 |
General Counsel | 1 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 7 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
PTC THERAPEUTICS, INC. | Health Technology |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
PFIZER, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Spark Therapeutics, Inc.
Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Jim Wang
- Experiencia